NEOK Bio, Inc., an oncology therapeutics company focused on the development of novel antibody drug conjugates (ADCs) for ...
January 21, 2026-- Opna Bio, a clinical-stage biopharmaceutical company focused on the discovery and development of novel oncology th ...
Zura Bio Limited said it has appointed Sandeep Kulkarni as chief executive, effective Wednesday. The clinical-stage biotechnology company said Kulkarni will continue serving as a director. Kulkarni ...
GlobalData on MSN
D3 Bio receives FDA clearance to advance KRAS inhibitor trials
The Phase II trial will assess the early efficacy, safety and pharmacokinetics of combining elisrasib with D3S 002.
After a cacophony of troubles hit the RNA editing biotech last fall, CEO Ram Aiyar is in San Francisco to develop ...
The collaboration will leverage Abalone Bio’s Functional Antibody Selection Technology platform for an undisclosed ...
Going into 2026, biotech company Ladder Bio is embracing a new identity.
Accelerated drug discovery and development platform Converge Bio Inc. today announced it has raised $25 million in ...
Learn how spectroscopy facilitates non-invasive, real-time bio-monitoring, enhancing decision-making in healthcare, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback